These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25379368)

  • 1. The Recency Period for Estimation of Human Immunodeficiency Virus Incidence by the AxSYM Avidity Assay and BED-Capture Enzyme Immunoassay in the Republic of Korea.
    Yu HK; Heo TY; Kim NY; Wang JS; Lee JK; Kim SS; Kee MK
    Osong Public Health Res Perspect; 2014 Aug; 5(4):187-92. PubMed ID: 25379368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil.
    Salustiano DM; Lima KO; Cavalcanti AM; Diaz RS; Lacerda HR
    Braz J Infect Dis; 2014; 18(4):449-53. PubMed ID: 24780363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of AxSYM Human Immunodeficiency Virus Assay to Identify Recent Human Immunodeficiency Virus Infections in Korean Human Immunodeficiency Virus-Positive Individuals.
    Wang JS; Kee MK; Choi BS; Kim SS
    Osong Public Health Res Perspect; 2015 Jun; 6(3):184-91. PubMed ID: 26430615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
    Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.
    Meixenberger K; Hauser A; Jansen K; Yousef KP; Fiedler S; von Kleist M; Norley S; Somogyi S; Hamouda O; Bannert N; Bartmeyer B; Kücherer C
    J Clin Microbiol; 2014 Aug; 52(8):2977-83. PubMed ID: 24920768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of methods to detect recent HIV type 1 infection in cross-sectionally collected specimens from a cohort of female sex workers in the Dominican Republic.
    Gupta SB; Murphy G; Koenig E; Adon C; Beyrer C; Celentano D; Khawaja S; Sifakis F; Parry JV; Straus W
    AIDS Res Hum Retroviruses; 2007 Dec; 23(12):1475-80. PubMed ID: 18160004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workers.
    Braunstein SL; Nash D; Kim AA; Ford K; Mwambarangwe L; Ingabire CM; Vyankandondera J; van de Wijgert JH
    PLoS One; 2011 Apr; 6(4):e18402. PubMed ID: 21532753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay.
    Longosz AF; Morrison CS; Chen PL; Arts E; Nankya I; Salata RA; Franco V; Quinn TC; Eshleman SH; Laeyendecker O
    J Acquir Immune Defic Syndr; 2014 Apr; 65(4):390-6. PubMed ID: 24583613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an antibody avidity index method for detecting recent human immunodeficiency virus type 1 infection using an automated chemiluminescence immunoassay.
    Fernández G; Manzardo C; Montoliu A; Campbell C; Fernández G; Casabona J; Miró JM; Matas L; Rivaya B; González V
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):238-42. PubMed ID: 25060663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an avidity assay for detection of recent HIV infections.
    Shepherd SJ; McAllister G; Kean J; Wallace LA; Templeton KE; Goldberg DJ; Gunson RN; Aitken C
    J Virol Methods; 2015 Jun; 217():42-9. PubMed ID: 25721468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel rapid HIV test for simultaneous detection of recent or long-term HIV type 1 infection using a single testing device.
    Granade TC; Nguyen S; Kuehl DS; Parekh BS
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):61-7. PubMed ID: 23281586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV incidence determination in the United States: a multiassay approach.
    Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
    J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
    Xu J; Wang H; Jiang Y; Ding G; Jia M; Wang G; Chu J; Smith K; Sharp GB; Chen RY; Jin X; Dong R; Han X; Shang H; Wang N
    Int J Infect Dis; 2010 Jul; 14(7):e608-12. PubMed ID: 20102792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.
    Serhir B; Hamel D; Doualla-Bell F; Routy JP; Beaulac SN; Legault M; Fauvel M; Tremblay C;
    PLoS One; 2016; 11(5):e0156023. PubMed ID: 27224023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.